Maravai LifeSciences Q1 Revenue Nearly Triples; Raises Full-Year 2021 Revenue Guidance
04:48 PM EDT, 05/10/2021 (MT Newswires) -- Maravai LifeSciences Holdings (MRVI) reported after markets closed on Monday Q1 EPS of $0.24, up from $0.09 a year earlier. Adjusted EPS was $0.26. Analysts polled by Capital IQ had called for $0.21.
Revenue totaled $148.2 million for the March quarter, up from $51 million a year earlier. Wall Street was looking for $139.5 million.
Looking ahead, the company said it now expects full-year 2021 revenue to be in the range of $680 million to $720 million. That compares with a range of $580 million to $630 million initially. Adjusted EPS is seen at $1.04-$1.12. Analysts are expecting revenue of $611 million and earnings of $0.92 per share.
Price: 35.82, Change: 0.00, Percent Change: 0.00